You have 9 free searches left this month | to do more

ipilimumab

Ipilimumab is a drug used to treat Melanoma, Metastatic Melanoma, Prostate Cancer, and other conditions. Ipilimumab is being actively studied in 262 studies and prior, has been studied in 99.

Top SponsorsTop SitesTop Investigators
Bristol-Myers SquibbLocal InstitutionInna Chen, MD
M.D. Anderson Cancer CenterDana Farber Cancer InstituteTheodore Sunki Hong
National Cancer Institute (NCI)Memorial Sloan Kettering Cancer CenterBradley A. McGregor
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
2022-01-19
Jan 19, 2022
S
Active, not recruiting
  • Neuroendocrine Tumors
  • Carcinoid Tumor
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
2021-12-15
Dec 15, 2021
D
Active, not recruiting
  • Thyroid Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-02-18
Feb 18, 2022
U
Active, not recruiting
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
2021-09-27
Sep 27, 2021
L
Terminated
  • Prostatic Neoplasms
  • PROSTVAC V/F
  • Ipilimumab
  • San Francisco, California
    University of California, San Francisco
2021-10-25
Oct 25, 2021
R
Active, not recruiting
  • Renal Cell Carcinoma
  • Washington, District of Columbia
  • +1 more
2022-01-10
Jan 10, 2022
M
Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-12
Jan 12, 2022
K
Active, not recruiting
  • Soft Tissue Sarcoma
  • Ipilimumab
  • +2 more
  • Stanford, California
    Stanford Medical Center
2022-02-02
Feb 2, 2022
D
Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
2022-02-15
Feb 15, 2022
D
Active, not recruiting
  • Head and Neck Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-02-22
Feb 22, 2022
N
Recruiting
  • Metastatic Solid Tumors
  • Treatment-Refractory Cancers
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
S
Recruiting
  • Basal Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins Hospital
2022-03-10
Mar 10, 2022
M
Active, not recruiting
  • Advanced Cancers
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-11
Feb 11, 2022
P
Recruiting
  • Kidney Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-03-22
Mar 22, 2022
D
Recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-11-10
Nov 10, 2021
U
Completed
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
H
Active, not recruiting
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
N
Recruiting
  • Mesothelioma
  • LMB-100
  • ipilimumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
A
Completed
  • Mucinous Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-12-02
Dec 2, 2021
H
Active, not recruiting
  • Small Cell Lung Cancer
  • Extensive-stage Small Cell Lung Cancer
  • Thoracic Radiation Therapy
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2022-02-14
Feb 14, 2022
A
Completed
  • Metastatic Melanoma
  • Ipilimumab
  • Stereotactic Body Radiation Therapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the Universirty of Pennsylvania
2021-07-19
Jul 19, 2021
N
Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Cleveland, Ohio
  • +1 more
2022-04-05
Apr 5, 2022
M
Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-11
Oct 11, 2021
A
Recruiting
  • Renal Cell Carcinoma
  • Renal Cell Carcinoma Stage IV
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
2022-03-14
Mar 14, 2022
D
Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
2021-09-27
Sep 27, 2021